References: Ambulatory antimicrobial therapy

Allwood MC, Stonkute D, Wallace A, Wilkinson AS, Hills T, Jamieson C, et al. Assessment of the stability of citrate-buffered flucloxacillin for injection when stored in two commercially available ambulatory elastomeric devices: INfusor LV (Baxter) and Accufuser (Woo Young Medical): a study compliant with the NHS Yellow Cover Document (YCD) requirements. Eur J Hosp Pharm 2020;27(2):90-4. https://www.ncbi.nlm.nih.gov/pubmed/32153771
Australian Commission on Safety and Quality in Health Care (ACSQHC). Antimicrobial Stewardship Clinical Care Standard. Sydney: Australian Commission on Safety and Quality in Health Care (ASQHC),; 2020. https://www.safetyandquality.gov.au/our-work/clinical-care-standards/antimicrobial-stewardship-clinical-care-standard
Australian Commission on Safety and Quality in Health Care (ACSQHC). Implementation Guide: Surveillance of Central Line-Associated Bloodstream Infection. Sydney: Australian Commission on Safety and Quality in Health Care (ASQHC),; 2019. Accessed 08 August 2023. https://www.safetyandquality.gov.au/publications-and-resources/resource-library/implementation-guide-surveillance-central-line-associated-bloodstream-infection-2019
Australian Commission on Safety and Quality in Health Care (ACSQHC). Remove safely and replace if needed [quality statement 10]. Sydney: ACSQHC. 2024; Accessed November 2024. https://www.safetyandquality.gov.au/standards/clinical-care-standards/management-peripheral-intravenous-catheters-clinical-care-standard/quality-statements/remove-safely-and-replace-if-needed
Carroll JA. Stability of Flucloxacillin in Elastomeric Infusion Devices. Journal of pharmacy practice and research 2005;35(2):90-3. https://onlinelibrary.wiley.com/doi/epdf/10.1002/j.2055-2335.2005.tb00313.x
Chapman ALN, Patel S, Horner C, Green H, Guleri A, Hedderwick S, et al. Updated good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults and children in the UK. JAC Antimicrob Resist 2019;1(2):dlz026. https://www.ncbi.nlm.nih.gov/pubmed/34222901
Docherty T, David M, Schneider J, O'Kane G, Morris J, Paavola C, et al. Antibiotics administered as continuous intravenous infusion over 24 hours by elastomeric devices to patients treated at home: a study of infusion efficiency. Journal of Pharmacy Practice and Research 2024;54(3):242-51. https://onlinelibrary.wiley.com/doi/abs/10.1002/jppr.1918
Docherty T, Montalto M, Leslie J, King K, Niblett S, Garrett T. Temperature profiles of antibiotic-containing elastomeric infusion devices used by ambulatory care patients. Am J Health Syst Pharm 2017;74(13):992-1001. https://www.ncbi.nlm.nih.gov/pubmed/28645997
Infectious Diseases Society of America (IDSA). Handbook of outpatient parenteral antimicrobial therapy for infectious diseases (eHandbook). 3rd ed. New York: CRG Publishing, a Division of the Curry Rockefeller Group, LLC and the Infectious Diseases Society of America; 2016. https://www.idsociety.org/opat-ehandbook/
Jamieson C. Stability testing of ceftazidime solutions for injection in elastomeric devices at 12 mg/mL and 25 mg/mL in 0.9% w/v saline for safe use in Outpatient Parenteral Antimicrobial Therapy (OPAT). British Society for Antimicrobial Chemotherapy, 2020. https://e-opat.com/wp-content/uploads/2020/01/OPAT2019-CAZPoster-28Nov.pdf
Jamieson C, Allwood MC, Stonkute D, Wallace A, Wilkinson AS, Hills T, et al. Investigation of meropenem stability after reconstitution: the influence of buffering and challenges to meet the NHS Yellow Cover Document compliance for continuous infusions in an outpatient setting. Eur J Hosp Pharm 2020;27(e1):e53-e7. https://www.ncbi.nlm.nih.gov/pubmed/32296506
Jamieson C, Drummond F, Hills T, Ozolina L, Gilchrist M, Seaton RA, et al. Assessment of ceftolozane/tazobactam stability in elastomeric devices and suitability for continuous infusion via outpatient parenteral antimicrobial therapy. JAC Antimicrob Resist 2021;3(3):dlab141. https://www.ncbi.nlm.nih.gov/pubmed/34676364
Jamieson C, Ozolina L, Seaton RA, Gilchrist M, Hills T, Drummond F, et al. Assessment of the stability of citrate-buffered piperacillin/tazobactam for continuous infusion when stored in two commercially available elastomeric devices for outpatient parenteral antimicrobial chemotherapy: a study compliant with the NHS Yellow Cover Document requirements. Eur J Hosp Pharm 2022;29(4):212-6. https://www.ncbi.nlm.nih.gov/pubmed/32978220
Jenkins A, Shanu S, Jamieson C, Santillo M. Systematic review of the stability of antimicrobial agents in elastomeric devices for outpatient parenteral antimicrobial therapy services based on NHS Yellow Cover Document standards. Eur J Hosp Pharm 2022;29(6):304-7. https://www.ncbi.nlm.nih.gov/pubmed/33990388
Kawabata Y. Effect of coefficient of viscosity and ambient temperature on the flow rate of drug solutions in infusion pumps. Pharm Dev Technol 2012;17(6):755-62. https://www.ncbi.nlm.nih.gov/pubmed/21615228
Legg A, Halford M, McCarthy K. Plasma concentrations resulting from continuous infusion of meropenem in a community-based outpatient program: A case series. Am J Health Syst Pharm 2020;77(24):2074-80. https://www.ncbi.nlm.nih.gov/pubmed/33274740
Levine DM, Pian J, Mahendrakumar K, Patel A, Saenz A, Schnipper JL. Hospital-Level Care at Home for Acutely Ill Adults: a Qualitative Evaluation of a Randomized Controlled Trial. J Gen Intern Med 2021;36(7):1965-73. https://www.ncbi.nlm.nih.gov/pubmed/33479931
Loeuille G, D'Huart E, Vigneron J, Nisse YE, Beiler B, Polo C, et al. Stability Studies of 16 Antibiotics for Continuous Infusion in Intensive Care Units and for Performing Outpatient Parenteral Antimicrobial Therapy. Antibiotics (Basel) 2022;11(4). https://www.ncbi.nlm.nih.gov/pubmed/35453211
McDougall D. Stability of Buffered Benzylpenicillin Solutions for Outpatient Parenteral Antimicrobial Therapy. Journal of pharmacy practice and research 2014;44:26-8. https://onlinelibrary.wiley.com/doi/abs/10.1002/j.2055-2335.2014.tb00012.x
Norris AH, Shrestha NK, Allison GM, Keller SC, Bhavan KP, Zurlo JJ, et al. 2018 Infectious Diseases Society of America Clinical Practice Guideline for the Management of Outpatient Parenteral Antimicrobial Therapy. Clin Infect Dis 2019;68(1):e1-e35. https://www.ncbi.nlm.nih.gov/pubmed/30423035
Patel RP, Jacob J, Sedeeq M, Ming LC, Wanandy T, Zaidi STR, et al. Stability of Cefazolin in Polyisoprene Elastomeric Infusion Devices. Clin Ther 2018;40(4):664-7. https://www.ncbi.nlm.nih.gov/pubmed/29496321
Smith E. Stability of buffered benzylpenicillin and flucloxacillin for a paediatric outpatient parenteral antibiotic therapy service. Journal of Pharmacy Practice and Research 2021;51(3):231-7.
Sriskandarajah S, Ritchie B, Eaton V, Sluggett JK, Hobbs JG, Daniel S, et al. Safety and Clinical Outcomes of Hospital in the Home. J Patient Saf 2020;16(2):123-9. https://www.ncbi.nlm.nih.gov/pubmed/32084091
Voumard R, Van Neyghem N, Cochet C, Gardiol C, Decosterd L, Buclin T, et al. Antibiotic stability related to temperature variations in elastomeric pumps used for outpatient parenteral antimicrobial therapy (OPAT). J Antimicrob Chemother 2017;72(5):1462-5. https://www.ncbi.nlm.nih.gov/pubmed/28158637
Walker SE, Iazzetta J, Law S, Biniecki K. Stability of commonly used antibiotic solutions in an elastomeric infusion device. Can J Hosp Pharm 2010;63(3):212-24. https://www.ncbi.nlm.nih.gov/pubmed/22478981